Skip to main content

Apolipoprotein CI/Apo-CI

Function

Inhibitor of lipoprotein binding to the low density lipoprotein (LDL) receptor, LDL receptor-related protein, and very low density lipoprotein (VLDL) receptor. Associates with high density lipoproteins (HDL) and the triacylglycerol-rich lipoproteins in the plasma and makes up about 10% of the protein of the VLDL and 2% of that of HDL. Appears to interfere directly with fatty acid uptake and is also the major plasma inhibitor of cholesteryl ester transfer protein (CETP). Modulates the interaction of APOE with beta-migrating VLDL and inhibits binding of beta-VLDL to the LDL receptor-related protein (By similarity). Binds free fatty acids and reduces their intracellular esterification.

Sequence similarities

Belongs to the apolipoprotein C1 family.

Tissue specificity

Adult and fetal liver.

Cellular localization

  • Secreted

Alternative names

Apolipoprotein C-I, Apo-CI, ApoC-I, Apolipoprotein C1, Apoc1

Target type

Proteins

Primary research area

Cardiovascular

We found 1 product in 1 category

Proteins & Peptides

Species of origin

Search our catalogue for 'Apolipoprotein CI/Apo-CI' (1)

Products